|
|
pattern specification involved in kidney development
|
GO:0061004 |
1 |
0.989
|
|
|
|
renal system pattern specification
|
GO:0072048 |
1 |
0.954
|
|
|
|
cilium assembly
|
GO:0042384 |
63 |
0.902
|
|
|
|
regulation of metanephros size
|
GO:0035566 |
1 |
0.877
|
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
2 |
0.701
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.683
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.585
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.472
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.457
|
|
|
|
mesonephric tubule formation
|
GO:0072172 |
1 |
0.439
|
|
|
|
tube closure
|
GO:0060606 |
3 |
0.421
|
|
|
|
mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0003337 |
4 |
0.401
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.380
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
2 |
0.371
|
|
|
|
nephric duct formation
|
GO:0072179 |
1 |
0.365
|
|
|
|
regulation of atp metabolic process
|
GO:1903578 |
29 |
0.353
|
|
|
|
ureter development
|
GO:0072189 |
3 |
0.329
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.327
|
|
|
|
regulation of atpase activity
|
GO:0043462 |
25 |
0.326
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
2 |
0.314
|
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
25 |
0.306
|
|
|
|
brain morphogenesis
|
GO:0048854 |
1 |
0.302
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.293
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.289
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.269
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.266
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.259
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
65 |
0.253
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.249
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.246
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.246
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.244
|
|
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.243
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.232
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
3 |
0.230
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.229
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
87 |
0.211
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.210
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.209
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.208
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.207
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.207
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
75 |
0.206
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.204
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.199
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.195
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.183
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.182
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.176
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.176
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.175
|
|
|
|
negative regulation of kidney development
|
GO:0090185 |
2 |
0.174
|
|
|
|
response to hexose
|
GO:0009746 |
20 |
0.174
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.167
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.166
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.164
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
36 |
0.158
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.157
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.157
|
|
|
|
eye pigmentation
|
GO:0048069 |
1 |
0.156
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.156
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.155
|
|
|
|
specification of organ identity
|
GO:0010092 |
3 |
0.153
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.150
|
|
|
|
microtubule anchoring at microtubule organizing center
|
GO:0072393 |
1 |
0.150
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.147
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.147
|
|
|
|
axis elongation
|
GO:0003401 |
4 |
0.146
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.144
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.144
|
|
|
|
metanephric nephron tubule morphogenesis
|
GO:0072282 |
1 |
0.144
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.142
|
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
38 |
0.140
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.140
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.139
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.139
|
|
|
|
positive regulation of atpase activity
|
GO:0032781 |
19 |
0.137
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.137
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.137
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.136
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.135
|
|
|
|
mesodermal cell fate commitment
|
GO:0001710 |
2 |
0.135
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.133
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.132
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.131
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.128
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.125
|
|
|
|
protein localization to cytoskeleton
|
GO:0044380 |
11 |
0.125
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.125
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.123
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.122
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.122
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.121
|
|
|
|
response to acid chemical
|
GO:0001101 |
66 |
0.118
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.118
|
|
|
|
mesodermal cell fate specification
|
GO:0007501 |
2 |
0.118
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.118
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
3 |
0.118
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
68 |
0.116
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.113
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.111
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.108
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.106
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.106
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.106
|
|
|
|
regulation of appetite
|
GO:0032098 |
1 |
0.105
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.105
|
|
|
|
nephric duct development
|
GO:0072176 |
4 |
0.102
|
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
26 |
0.102
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.102
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.101
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.101
|
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.100
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.100
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
4 |
0.100
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.100
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.100
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.097
|
|
|
|
sensory perception of smell
|
GO:0007608 |
2 |
0.096
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.096
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
64 |
0.096
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
26 |
0.095
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.094
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.094
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
56 |
0.092
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.090
|
|
|
|
regulation of cilium movement
|
GO:0003352 |
3 |
0.090
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.090
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.090
|
|
|
|
oxidoreduction coenzyme metabolic process
|
GO:0006733 |
19 |
0.090
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.089
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
67 |
0.089
|
|
|
|
maintenance of protein location in cell
|
GO:0032507 |
56 |
0.089
|
|
|
|
regulation of glomerulus development
|
GO:0090192 |
3 |
0.089
|
|
|
|
maintenance of location in cell
|
GO:0051651 |
62 |
0.089
|
|
|
|
nadh metabolic process
|
GO:0006734 |
1 |
0.088
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.086
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.083
|
|
|
|
convergent extension involved in gastrulation
|
GO:0060027 |
1 |
0.081
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.081
|
|
|
|
cilium dependent cell motility
|
GO:0060285 |
4 |
0.080
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.080
|
|
|
|
tissue homeostasis
|
GO:0001894 |
63 |
0.080
|
|
|
|
regulation of kidney size
|
GO:0035564 |
2 |
0.079
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.079
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.078
|
|
|
|
cellular amino acid biosynthetic process
|
GO:0008652 |
30 |
0.078
|
|
|
|
convergent extension
|
GO:0060026 |
1 |
0.077
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.076
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.076
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.075
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.074
|
|
|
|
nephron tubule formation
|
GO:0072079 |
1 |
0.074
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.074
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.072
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.072
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.072
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.071
|
|
|
|
atp catabolic process
|
GO:0006200 |
157 |
0.071
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.070
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.070
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.070
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.069
|
|
|
|
cytokinesis
|
GO:0000910 |
96 |
0.069
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.069
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.069
|
|
|
|
regulation of epithelial cell differentiation involved in kidney development
|
GO:2000696 |
4 |
0.068
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.067
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.067
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.067
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.066
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.066
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.066
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.065
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.065
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
24 |
0.064
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.063
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.063
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.061
|
|
|
|
negative regulation of cytolysis
|
GO:0045918 |
3 |
0.060
|
|
|
|
glycolytic process
|
GO:0006096 |
17 |
0.059
|
|
|
|
single organism carbohydrate catabolic process
|
GO:0044724 |
33 |
0.059
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.057
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.057
|
|
|
|
cilium organization
|
GO:0044782 |
68 |
0.056
|
|
|
|
embryonic camera type eye morphogenesis
|
GO:0048596 |
2 |
0.056
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.056
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.055
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.055
|
|
|
|
response to camp
|
GO:0051591 |
25 |
0.054
|
|
|
|
response to purine containing compound
|
GO:0014074 |
40 |
0.054
|
|
|
|
response to monosaccharide
|
GO:0034284 |
20 |
0.054
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.054
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.054
|
|
|
|
response to food
|
GO:0032094 |
1 |
0.054
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.054
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.053
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.052
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.052
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
22 |
0.052
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
3 |
0.051
|
|
|
|
neural tube closure
|
GO:0001843 |
3 |
0.051
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
2 |
0.050
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.050
|
|
|
|
golgi vesicle transport
|
GO:0048193 |
80 |
0.050
|
|
|
|
optic nerve development
|
GO:0021554 |
2 |
0.050
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.049
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.049
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.049
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.048
|
|
|
|
embryonic camera type eye formation
|
GO:0060900 |
2 |
0.048
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.048
|
|
|
|
response to carbohydrate
|
GO:0009743 |
21 |
0.047
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
19 |
0.047
|
|
|
|
nephric duct morphogenesis
|
GO:0072178 |
1 |
0.047
|
|
|
|
regulation of organelle assembly
|
GO:1902115 |
40 |
0.047
|
|
|
|
cellular response to peptide
|
GO:1901653 |
59 |
0.047
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.047
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.047
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.047
|
|
|
|
maintenance of protein localization in organelle
|
GO:0072595 |
15 |
0.047
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.046
|
|
|
|
microtubule based movement
|
GO:0007018 |
32 |
0.046
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.046
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.046
|
|
|
|
hippocampus development
|
GO:0021766 |
1 |
0.046
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.045
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.045
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.045
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.045
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.045
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.044
|
|
|
|
hexose metabolic process
|
GO:0019318 |
55 |
0.044
|
|
|
|
cell projection assembly
|
GO:0030031 |
126 |
0.044
|
|
|
|
pyridine nucleotide metabolic process
|
GO:0019362 |
14 |
0.044
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.043
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.043
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.043
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
3 |
0.042
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.042
|
|
|
|
response to amino acid
|
GO:0043200 |
14 |
0.042
|
|
|
|
metanephric nephron tubule development
|
GO:0072234 |
3 |
0.042
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.041
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
1 |
0.041
|
|
|
|
head development
|
GO:0060322 |
108 |
0.040
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.040
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.040
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.040
|
|
|
|
cilium movement
|
GO:0003341 |
9 |
0.040
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.040
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.040
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
1 |
0.040
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.039
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.039
|
|
|
|
response to corticosteroid
|
GO:0031960 |
15 |
0.039
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
23 |
0.039
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.039
|
|
|
|
cilium or flagellum dependent cell motility
|
GO:0001539 |
4 |
0.039
|
|
|
|
gastrulation
|
GO:0007369 |
51 |
0.039
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.038
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
10 |
0.038
|
|
|
|
otic vesicle development
|
GO:0071599 |
1 |
0.038
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
48 |
0.038
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.038
|
|
|
|
regulation of cilium assembly
|
GO:1902017 |
6 |
0.037
|
|
|
|
cerebral cortex development
|
GO:0021987 |
10 |
0.037
|
|
|
|
s shaped body morphogenesis
|
GO:0072050 |
4 |
0.037
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
11 |
0.037
|
|
|
|
metanephric distal tubule development
|
GO:0072235 |
2 |
0.037
|
|
|
|
regulation of apoptotic process involved in morphogenesis
|
GO:1902337 |
1 |
0.036
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.036
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.036
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.036
|
|
|
|
metanephric tubule development
|
GO:0072170 |
3 |
0.036
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.035
|
|
|
|
nicotinamide nucleotide metabolic process
|
GO:0046496 |
14 |
0.035
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.035
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
56 |
0.034
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.034
|
|
|
|
cellular response to hydrogen peroxide
|
GO:0070301 |
37 |
0.034
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.034
|
|
|
|
tube formation
|
GO:0035148 |
10 |
0.034
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.033
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
2 |
0.033
|
|
|
|
notch signaling pathway
|
GO:0007219 |
31 |
0.033
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.033
|
|
|
|
response to zinc ion
|
GO:0010043 |
12 |
0.032
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
48 |
0.032
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.032
|
|
|
|
negative regulation of response to nutrient levels
|
GO:0032108 |
5 |
0.032
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
12 |
0.032
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.032
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.032
|
|
|
|
distal tubule development
|
GO:0072017 |
4 |
0.032
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.031
|
|
|
|
renal vesicle development
|
GO:0072087 |
4 |
0.031
|
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.031
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.031
|
|
|
|
pyridine containing compound metabolic process
|
GO:0072524 |
18 |
0.031
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.031
|
|
|
|
system process
|
GO:0003008 |
349 |
0.031
|
|
|
|
thyroid hormone generation
|
GO:0006590 |
2 |
0.031
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
18 |
0.031
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
1 |
0.031
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.031
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.031
|
|
|
|
response to organophosphorus
|
GO:0046683 |
41 |
0.030
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.030
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.030
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.030
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.030
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.030
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.030
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.030
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.030
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.029
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.029
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.029
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.029
|
|
|
|
mesodermal cell differentiation
|
GO:0048333 |
10 |
0.029
|
|
|
|
negative regulation of response to external stimulus
|
GO:0032102 |
83 |
0.029
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.028
|
|
|
|
golgi to plasma membrane transport
|
GO:0006893 |
21 |
0.028
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.028
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.028
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.028
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
2 |
0.027
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.027
|
|
|
|
pigment granule localization
|
GO:0051875 |
7 |
0.027
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.027
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.027
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.027
|
|
|
|
metanephric tubule morphogenesis
|
GO:0072173 |
1 |
0.027
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.027
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.026
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.026
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
10 |
0.026
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.026
|
|
|
|
camera type eye photoreceptor cell differentiation
|
GO:0060219 |
1 |
0.026
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.026
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.026
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.026
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.026
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
41 |
0.026
|
|
|
|
cranial nerve formation
|
GO:0021603 |
1 |
0.025
|
|
|
|
fat cell differentiation
|
GO:0045444 |
32 |
0.025
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.025
|
|
|
|
renal vesicle morphogenesis
|
GO:0072077 |
4 |
0.025
|
|
|
|
adult behavior
|
GO:0030534 |
18 |
0.025
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.025
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.025
|
|
|
|
growth
|
GO:0040007 |
202 |
0.025
|
|
|
|
cochlea development
|
GO:0090102 |
1 |
0.025
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.025
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
71 |
0.025
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.025
|
|
|
|
negative regulation of response to extracellular stimulus
|
GO:0032105 |
5 |
0.024
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.024
|
|
|
|
signal release
|
GO:0023061 |
70 |
0.024
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.024
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.024
|
|
|
|
nephron tubule epithelial cell differentiation
|
GO:0072160 |
3 |
0.024
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.024
|
|
|
|
eye morphogenesis
|
GO:0048592 |
16 |
0.024
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.023
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.023
|
|
|
|
microtubule anchoring
|
GO:0034453 |
24 |
0.023
|
|
|
|
organelle localization
|
GO:0051640 |
84 |
0.023
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
50 |
0.023
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.023
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.023
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.023
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.023
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.023
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.022
|
|
|
|
response to interleukin 6
|
GO:0070741 |
15 |
0.022
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.022
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.022
|
|
|
|
response to transition metal nanoparticle
|
GO:1990267 |
29 |
0.022
|
|
|
|
glomerulus development
|
GO:0032835 |
15 |
0.022
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.022
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.022
|
|
|
|
positive regulation of organelle assembly
|
GO:1902117 |
17 |
0.022
|
|
|
|
metanephric collecting duct development
|
GO:0072205 |
2 |
0.022
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
52 |
0.021
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.021
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.021
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.021
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.021
|
|
|
|
pancreas development
|
GO:0031016 |
19 |
0.021
|
|
|
|
response to insulin
|
GO:0032868 |
45 |
0.021
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
13 |
0.021
|
|
|
|
telencephalon development
|
GO:0021537 |
17 |
0.021
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.021
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.021
|
|
|
|
peptide transport
|
GO:0015833 |
74 |
0.021
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.021
|
|
|
|
pigmentation
|
GO:0043473 |
22 |
0.021
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.021
|
|
|
|
metanephric renal vesicle morphogenesis
|
GO:0072283 |
4 |
0.021
|
|
|
|
neural retina development
|
GO:0003407 |
8 |
0.021
|
|
|
|
cell differentiation involved in metanephros development
|
GO:0072202 |
3 |
0.020
|
|
|
|
metanephric nephron development
|
GO:0072210 |
9 |
0.020
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.020
|
|
|
|
regulation of cytokinesis
|
GO:0032465 |
45 |
0.020
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
15 |
0.020
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.020
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.020
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.020
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.020
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.020
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.020
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
73 |
0.020
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.019
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.019
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.019
|
|
|
|
protein localization to centrosome
|
GO:0071539 |
5 |
0.019
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.019
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.019
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.019
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.019
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.019
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.019
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.019
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.018
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.018
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.018
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.018
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.018
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.018
|
|
|
|
metanephric s shaped body morphogenesis
|
GO:0072284 |
4 |
0.018
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
14 |
0.018
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.018
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.018
|
|
|
|
thyroid hormone metabolic process
|
GO:0042403 |
4 |
0.018
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.018
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.018
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
14 |
0.018
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.018
|
|
|
|
subpallium development
|
GO:0021544 |
2 |
0.018
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.017
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.017
|
|
|
|
positive regulation of atp catabolic process
|
GO:1903291 |
19 |
0.017
|
|
|
|
centrosome organization
|
GO:0051297 |
58 |
0.017
|
|
|
|
response to peptide hormone
|
GO:0043434 |
61 |
0.017
|
|
|
|
kidney epithelium development
|
GO:0072073 |
25 |
0.017
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.017
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.017
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.017
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.017
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.016
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.016
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.016
|
|
|
|
positive regulation of thyroid hormone generation
|
GO:2000611 |
2 |
0.016
|
|
|
|
positive regulation of atp metabolic process
|
GO:1903580 |
20 |
0.016
|
|
|
|
cochlea morphogenesis
|
GO:0090103 |
1 |
0.016
|
|
|
|
cellular response to reactive oxygen species
|
GO:0034614 |
50 |
0.016
|
|
|
|
negative regulation of metanephros development
|
GO:0072217 |
1 |
0.016
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.016
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
8 |
0.016
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
30 |
0.016
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.016
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
62 |
0.016
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.016
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.016
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.015
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.015
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.015
|
|
|
|
metanephric nephron morphogenesis
|
GO:0072273 |
7 |
0.015
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.015
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.015
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.015
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.015
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.015
|
|
|
|
pigment metabolic process
|
GO:0042440 |
16 |
0.015
|
|
|
|
liver development
|
GO:0001889 |
9 |
0.015
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.015
|
|
|
|
aging
|
GO:0007568 |
66 |
0.015
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.015
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
114 |
0.015
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.015
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
52 |
0.015
|
|
|
|
response to fructose
|
GO:0009750 |
1 |
0.015
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.014
|
|
|
|
developmental growth
|
GO:0048589 |
48 |
0.014
|
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.014
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.014
|
|
